ATE453381T1 - Nicht-pegylierte lang-zirkulierende liposome - Google Patents

Nicht-pegylierte lang-zirkulierende liposome

Info

Publication number: ATE453381T1
Authority: AT; Austria
Prior art keywords: liposomes; phospholipid; sucrose; ammonium sulphate; hydration
Prior art date: 2002-12-31

Application number

AT03258252T

Other languages

English (en)

Inventor

Gautam Vinod Daftary

Srikanth Annappa Pai

Sangeeta Hanurmesh Rivankar

Original Assignee

Bharat Serums & Vaccines Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-31

Filing date

2003-12-31

Publication date

2010-01-15

2003-12-31 Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd

2010-01-15 Application granted granted Critical

2010-01-15 Publication of ATE453381T1 publication Critical patent/ATE453381T1/de

Links

239000002502 liposome Substances 0.000 title abstract 3
230000036571 hydration Effects 0.000 abstract 3
238000006703 hydration reaction Methods 0.000 abstract 3
BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 abstract 2
229910052921 ammonium sulfate Inorganic materials 0.000 abstract 2
235000011130 ammonium sulphate Nutrition 0.000 abstract 2
239000001166 ammonium sulphate Substances 0.000 abstract 2
150000002632 lipids Chemical class 0.000 abstract 2
150000003904 phospholipids Chemical class 0.000 abstract 2
239000002904 solvent Substances 0.000 abstract 2
MWWSFMDVAYGXBV-RUELKSSGSA-N Doxorubicin hydrochloride Chemical compound Cl.O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 MWWSFMDVAYGXBV-RUELKSSGSA-N 0.000 abstract 1
229930182558 Sterol Natural products 0.000 abstract 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract 1
229930006000 Sucrose Natural products 0.000 abstract 1
239000007853 buffer solution Substances 0.000 abstract 1
239000000032 diagnostic agent Substances 0.000 abstract 1
229940039227 diagnostic agent Drugs 0.000 abstract 1
229960002918 doxorubicin hydrochloride Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000887 hydrating effect Effects 0.000 abstract 1
239000000243 solution Substances 0.000 abstract 1
150000003432 sterols Chemical class 0.000 abstract 1
235000003702 sterols Nutrition 0.000 abstract 1
239000005720 sucrose Substances 0.000 abstract 1
229940124597 therapeutic agent Drugs 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A61K9/1278—Post-loading, e.g. by ion or pH gradient

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Dispersion Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT03258252T 2002-12-31 2003-12-31 Nicht-pegylierte lang-zirkulierende liposome ATE453381T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IN1101MU2002		2002-12-31

Publications (1)

Publication Number	Publication Date
ATE453381T1 true ATE453381T1 (de)	2010-01-15

Family

ID=32500467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03258252T ATE453381T1 (de)	2002-12-31	2003-12-31	Nicht-pegylierte lang-zirkulierende liposome

Country Status (18)

Country	Link
EP (1)	EP1435231B8 (de)
JP (1)	JP5355842B2 (de)
KR (2)	KR101171045B1 (de)
CN (1)	CN1756533B (de)
AT (1)	ATE453381T1 (de)
AU (1)	AU2003303368B2 (de)
BR (1)	BR0317882A (de)
CA (1)	CA2511464C (de)
DE (1)	DE60330745D1 (de)
DK (1)	DK1435231T3 (de)
EA (1)	EA008930B1 (de)
ES (1)	ES2337563T3 (de)
IL (1)	IL169364A (de)
MX (1)	MXPA05007102A (de)
NZ (1)	NZ540778A (de)
PT (1)	PT1435231E (de)
WO (1)	WO2004058140A2 (de)
ZA (1)	ZA200504850B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101743020A (zh)	2007-05-16	2010-06-16	Ktb肿瘤研究有限责任公司	低粘度蒽环制剂
WO2010113983A1 (ja)	2009-03-30	2010-10-07	エーザイ・アール・アンド・ディー・マネジメント株式会社	リポソーム組成物の製造方法
CN102369008B (zh)	2009-03-30	2014-10-29	卫材R&D管理有限公司	脂质体组合物
EP2680820B1 (de) *	2011-03-01	2022-11-02	2-BBB Medicines B.V.	Fortschrittliches, aktives liposomales laden von schwer wasserlöslichen substanzen
UA123665C2 (uk) *	2014-11-25	2021-05-12	Кюрадігм Сас	Фармацевтична композиція, її одержання і застосування
WO2017188350A1 (ja)	2016-04-28	2017-11-02	エーザイ・アール・アンド・ディー・マネジメント株式会社	腫瘍の成長を抑制する方法
EP3518931A4 (de) *	2016-09-27	2020-05-13	Vertex Pharmaceuticals Incorporated	Verfahren zur behandlung von krebs mit einer kombination aus dna-schädigenden substanzen und dna-pk-inhibitoren
US12036204B2 (en)	2019-07-26	2024-07-16	Eisai R&D Management Co., Ltd.	Pharmaceutical composition for treating tumor
US11083705B2 (en)	2019-07-26	2021-08-10	Eisai R&D Management Co., Ltd.	Pharmaceutical composition for treating tumor
CN116570775B (zh) *	2023-05-16	2024-08-02	万瑞飞鸿(北京)医疗器材有限公司	一种药物涂层、血管支架及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4235871A (en) *	1978-02-24	1980-11-25	Papahadjopoulos Demetrios P	Method of encapsulating biologically active materials in lipid vesicles
EP0153955A1 (de) *	1983-09-06	1985-09-11	Health Research, Inc.	Verfahren zum verabreichen von liposomen zum herabsetzen der toxizität eines antitumor-arzneimittels
CA1270198C (en) *	1984-08-08	1990-06-12	Marcel B Bally	ENCAPSULATION OF ANTINEOPLASTIC AGENTS IN LIPOSONES
US4880635B1 (en) *	1984-08-08	1996-07-02	Liposome Company	Dehydrated liposomes
US4920016A (en)	1986-12-24	1990-04-24	Linear Technology, Inc.	Liposomes with enhanced circulation time
CA1338702C (en) *	1987-03-05	1996-11-12	Lawrence D. Mayer	High drug:lipid formulations of liposomal- antineoplastic agents
JPH0720857B2 (ja)	1988-08-11	1995-03-08	テルモ株式会社	リポソームおよびその製法
IL91664A (en) *	1988-09-28	1993-05-13	Yissum Res Dev Co	Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
US6132763A (en)	1988-10-20	2000-10-17	Polymasc Pharmaceuticals Plc	Liposomes
US5013556A (en) *	1989-10-20	1991-05-07	Liposome Technology, Inc.	Liposomes with enhanced circulation time
ATE252372T1 (de) *	1996-08-23	2003-11-15	Sequus Pharm Inc	Liposome enthaltend cisplatin
KR100679906B1 (ko) *	1998-09-16	2007-02-07	알자 코포레이션	리포솜-엔트랩된 토포이소머라제 억제제
KR20000061075A (ko) *	1999-03-23	2000-10-16	린 중친	리포솜의 응집을 방지하기 위한 방법 및 조성물
GB0111279D0 (en) *	2001-05-10	2001-06-27	Nycomed Imaging As	Radiolabelled liposomes

2003
- 2003-12-31 BR BR0317882-0A patent/BR0317882A/pt not_active IP Right Cessation
- 2003-12-31 AT AT03258252T patent/ATE453381T1/de active
- 2003-12-31 CA CA2511464A patent/CA2511464C/en not_active Expired - Fee Related
- 2003-12-31 KR KR1020117014172A patent/KR101171045B1/ko not_active Expired - Fee Related
- 2003-12-31 DE DE60330745T patent/DE60330745D1/de not_active Expired - Lifetime
- 2003-12-31 MX MXPA05007102A patent/MXPA05007102A/es active IP Right Grant
- 2003-12-31 NZ NZ540778A patent/NZ540778A/en not_active IP Right Cessation
- 2003-12-31 JP JP2004562836A patent/JP5355842B2/ja not_active Expired - Fee Related
- 2003-12-31 WO PCT/IN2003/000424 patent/WO2004058140A2/en not_active Ceased
- 2003-12-31 CN CN2003801100257A patent/CN1756533B/zh not_active Expired - Fee Related
- 2003-12-31 DK DK03258252.0T patent/DK1435231T3/da active
- 2003-12-31 KR KR1020057012107A patent/KR101133084B1/ko not_active Expired - Fee Related
- 2003-12-31 AU AU2003303368A patent/AU2003303368B2/en not_active Ceased
- 2003-12-31 EA EA200500850A patent/EA008930B1/ru not_active IP Right Cessation
- 2003-12-31 EP EP03258252A patent/EP1435231B8/de not_active Expired - Lifetime
- 2003-12-31 ES ES03258252T patent/ES2337563T3/es not_active Expired - Lifetime
- 2003-12-31 PT PT03258252T patent/PT1435231E/pt unknown
2005
- 2005-06-14 ZA ZA200504850A patent/ZA200504850B/en unknown
- 2005-06-23 IL IL169364A patent/IL169364A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
KR20050088233A (ko)	2005-09-02
CA2511464C (en)	2011-08-23
EA008930B1 (ru)	2007-08-31
WO2004058140A3 (en)	2004-10-28
AU2003303368B2 (en)	2010-06-17
EP1435231A1 (de)	2004-07-07
KR20110075051A (ko)	2011-07-05
PT1435231E (pt)	2010-04-08
WO2004058140B1 (en)	2004-12-16
AU2003303368A1 (en)	2004-07-22
KR101171045B1 (ko)	2012-08-03
CA2511464A1 (en)	2004-07-15
WO2004058140A2 (en)	2004-07-15
JP5355842B2 (ja)	2013-11-27
EP1435231B1 (de)	2009-12-30
CN1756533A (zh)	2006-04-05
DE60330745D1 (de)	2010-02-11
IL169364A (en)	2012-05-31
HK1089946A1 (en)	2006-12-15
IL169364A0 (en)	2007-07-04
EP1435231B8 (de)	2010-03-03
ZA200504850B (en)	2006-08-30
JP2006513189A (ja)	2006-04-20
EA200500850A1 (ru)	2006-02-24
NZ540778A (en)	2008-04-30
KR101133084B1 (ko)	2012-04-04
MXPA05007102A (es)	2005-08-26
CN1756533B (zh)	2010-06-16
DK1435231T3 (da)	2010-04-26
BR0317882A (pt)	2005-12-13
ES2337563T3 (es)	2010-04-27

Legal Events

Date

Code

Title

Description

2010-07-15

UEP

Publication of translation of european patent specification

Ref document number: 1435231

Country of ref document: EP

Publication	Publication Date	Title
ATE453381T1 (de)	2010-01-15	Nicht-pegylierte lang-zirkulierende liposome
AR023055A1 (es)	2002-09-04	Una formulacion farmaceutica de liposoma mixta con vesiculas multilaminar y un proceso para su preparacion
EA200300457A1 (ru)	2003-10-30	Кристаллический моногидрат, способ его получения и его применение для получения лекарственного средства
ITMI991803A0 (it)	1999-08-09	Processo per la preparazione di formulazioni acquose per uso oftalmico
ES2088385T3 (es)	1996-08-16	Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
ES2123284T3 (es)	1999-01-01	Un sistema de suministro liposomico para agentes biologicamente activos.
AR002262A1 (es)	1998-03-11	Composicion y metodo para el tratamiento de enfermedades fungales de las unas y un vendaje adaptado para la administracion topica de medicacion a lasunas.
DE3864495D1 (de)	1991-10-02	Amphotericin b-liposomzubereitung.
BR0117106A (pt)	2004-08-17	Compostos de lipossoma de microesfera de gás
HK1046101A1 (zh)	2002-12-27	那格列奈和其它抗糖尿病藥劑的藥物組合物
ITMI991884A0 (it)	1999-09-08	Composizioni per la cura della pelle e loro impiego nel curare una pel le danneggiata
DK0785773T3 (da)	2001-01-29	Etherlipidliposomer og deres terapeutiske anvendelse
AR049137A1 (es)	2006-06-28	Formulacion de irinotecan en vesicula cerrada, para el tratamiento del cancer
RU99124771A (ru)	2001-09-20	Применение альфа-метил-п-тирозина для ингибирования продуцирования меланина в меланоцитах радужной оболочки
IT8812585A0 (it)	1988-11-16	Preparato, in particolare preparato cosmetico antisolare, nonche' metodo per l'introduzione di una sostanza attiva nella pelle
DE60110057D1 (de)	2005-05-19	Liposomen enthaltend eine eingeschlossene verbindung in übersattigter lösung
FI964936A0 (fi)	1996-12-10	Bentsopyraaneja ja niiden käyttö terapeuttisina aineina
FI883338A7 (fi)	1989-01-17	Doksorubisiinihydrokloridin vesiliuoksia
BR9917389A (pt)	2002-03-05	Formulações tópicas compreendendo agentes de penetração na pele e o uso das mesmas
IT1296305B1 (it)	1999-06-25	Inibitori di metalloproteinasi loro uso terapeutico e procedimento per la produzione del composto di partenza nella loro
RU2003104017A (ru)	2004-08-20	Ингибиторы тромбина, содержащие аминоизохинолиновую группу
PT1189932E (pt)	2003-09-30	Derivados de echinocandina processo para a sua preparacao e sua utilizacao como agentes antifungicos
RU93019277A (ru)	1995-12-10	Раствор для защиты и лечения заболеваний и повреждения роговицы "визитон"
WO2003000232A3 (en)	2004-02-26	Method for preparation of vesicles loaded with immunostimulator y oligodeoxynucleotides
CO5180574A1 (es)	2002-07-30	Micofenolato mofetil en asociacion con peg-inf-a